Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02509845 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects
A Phase 2 study, sponsored by Armata Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 64
- Enrollment target
NCT02509845 is a Phase 2 study that has completed, run by Armata Pharmaceuticals. The registered enrollment target is 64 participants.
The verdict
NCT02509845, a Phase 2 study, has completed, sponsored by Armata Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of the clinical study is to evaluate the safety and bacterial impact of study drug (C16G2) administered in multiple oral gel doses to adolescent and adult dental subjects.
Interventions
- OTHER Placebo
- DRUG C16G2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02509845
The ClinicalTrials.gov registry entry for NCT02509845 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Armata Pharmaceuticals, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02509845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02509845 about?
NCT02509845 is a clinical study titled "Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects". The purpose of the clinical study is to evaluate the safety and bacterial impact of study drug (C16G2) administered in multiple oral gel doses to adolescent and adult dental subjects.
What is the current status of trial NCT02509845?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 64 participants. The study started on 2015-07. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02509845?
The interventions under investigation include: Placebo (OTHER), C16G2 (DRUG).
Who is sponsoring clinical trial NCT02509845?
This trial is sponsored by Armata Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.